Shares of Prothena Co. plc (NASDAQ:PRTA – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $21.91 and last traded at $22.18, with a volume of 40918 shares trading hands. The stock had previously closed at $23.54. Analyst Ratings Changes Several research firms have commented […]
Shares of Prothena Co. plc (NASDAQ:PRTA – Get Free Report) have been given an average rating of “Moderate Buy” by the nine brokerages that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year […]
Prothena Co. plc (NASDAQ:PRTA – Free Report) – Analysts at Cantor Fitzgerald issued their FY2024 EPS estimates for Prothena in a research note issued to investors on Monday, February 19th. Cantor Fitzgerald analyst C. Duncan anticipates that the biotechnology company will earn ($4.61) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating […]
Silverarc Capital Management LLC cut its stake in Prothena Co. plc (NASDAQ:PRTA – Free Report) by 46.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,629 shares of the biotechnology company’s stock after selling 23,092 shares during the period. Silverarc Capital Management […]
Silverarc Capital Management LLC decreased its stake in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) by 46.4% in the 3rd quarter, Holdings Channel reports. The fund owned 26,629 shares of the biotechnology company’s stock after selling 23,092 shares during the quarter. Silverarc Capital Management LLC’s holdings in Prothena were worth $1,285,000 as of […]